Profarma Distribuidora de Produtos Farmaceuticos SA
BOVESPA:PFRM3
Operating Income
Forecast
For the last 13 years the
compound annual growth rate for
Profarma Distribuidora de Produtos Farmaceuticos SA's operating income is
12%.
The projected
CAGR
for the next 6 years is
-26%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PFRM3's stock price target?
Not Available
PFRM3 doesn't have any price targets made by Wall Street professionals.
What is Profarma Distribuidora de Produtos Farmaceuticos SA's Revenue forecast?
Projected CAGR
-13%
For the last 13 years the
compound annual growth rate for
Profarma Distribuidora de Produtos Farmaceuticos SA's revenue is
10%.
The projected
CAGR
for the next 6 years is
-13%.
What is Profarma Distribuidora de Produtos Farmaceuticos SA's Operating Income forecast?
Projected CAGR
-26%
For the last 13 years the
compound annual growth rate for
Profarma Distribuidora de Produtos Farmaceuticos SA's operating income is
12%.
The projected
CAGR
for the next 6 years is
-26%.
